These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 7983722)

  • 1. A mutant v-rel with increased ability to transform B lymphocytes.
    Romero P; Humphries EH
    J Virol; 1995 Jan; 69(1):301-7. PubMed ID: 7983722
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction of the v-Rel oncoprotein with NF-kappaB and IkappaB proteins: heterodimers of a transformation-defective v-Rel mutant and NF-2 are functional in vitro and in vivo.
    White DW; Pitoc GA; Gilmore TD
    Mol Cell Biol; 1996 Mar; 16(3):1169-78. PubMed ID: 8622661
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutational analysis of v-rel, the oncogene of reticuloendotheliosis virus strain T.
    Bhat GV; Temin HM
    Oncogene; 1990 May; 5(5):625-34. PubMed ID: 2189101
    [TBL] [Abstract][Full Text] [Related]  

  • 4. v-Rel and c-Rel are differentially affected by mutations at a consensus protein kinase recognition sequence.
    Mosialos G; Gilmore TD
    Oncogene; 1993 Mar; 8(3):721-30. PubMed ID: 8437855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of a serine-rich domain essential for the transcriptional, antiapoptotic, and transforming activities of the v-Rel oncoprotein.
    Chen C; Agnès F; Gélinas C
    Mol Cell Biol; 1999 Jan; 19(1):307-16. PubMed ID: 9858554
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-2 and CrmA have different effects on transformation, apoptosis and the stability of I kappa B-alpha in chicken spleen cells transformed by temperature-sensitive v-Rel oncoproteins.
    White DW; Gilmore TD
    Oncogene; 1996 Sep; 13(5):891-9. PubMed ID: 8806678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolution of the oncogenic potential of v-rel: rel-induced expression of immunoregulatory receptors correlates with tumor development and in vitro transformation.
    Nehyba J; Hrdlicková R; Humphries EH
    J Virol; 1994 Apr; 68(4):2039-50. PubMed ID: 8138989
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evolution of c-rel oncogenic potential.
    Hrdlicková R; Nehyba J; Humphries EH
    J Virol; 1994 Apr; 68(4):2371-82. PubMed ID: 8139023
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutations in the DNA-binding and dimerization domains of v-Rel are responsible for altered kappa B DNA-binding complexes in transformed cells.
    Hrdlicková R; Nehyba J; Bose HR
    J Virol; 1995 Jun; 69(6):3369-80. PubMed ID: 7745683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The v-rel oncogene: insights into the mechanism of transcriptional activation, repression, and transformation.
    Walker WH; Stein B; Ganchi PA; Hoffman JA; Kaufman PA; Ballard DW; Hannink M; Greene WC
    J Virol; 1992 Aug; 66(8):5018-29. PubMed ID: 1321284
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Temperature-sensitive transforming mutants of the v-rel oncogene.
    White DW; Gilmore TD
    J Virol; 1993 Nov; 67(11):6876-81. PubMed ID: 8411392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NF-kappa B p100 is one of the high-molecular-weight proteins complexed with the v-Rel oncoprotein in transformed chicken spleen cells.
    Sif S; Gilmore TD
    J Virol; 1993 Dec; 67(12):7612-7. PubMed ID: 8230480
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The v-rel oncogene promotes malignant T-cell leukemia/lymphoma in transgenic mice.
    Carrasco D; Rizzo CA; Dorfman K; Bravo R
    EMBO J; 1996 Jul; 15(14):3640-50. PubMed ID: 8670867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations in the rel-homology domain alter the biochemical properties of v-rel and render it transformation defective in chicken embryo fibroblasts.
    Morrison LE; Boehmelt G; Enrietto PJ
    Oncogene; 1992 Jun; 7(6):1137-47. PubMed ID: 1594245
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of v-rel in a replication competent virus: transformation and biochemical characterization.
    Morrison LE; Boehmelt G; Beug H; Enrietto PJ
    Oncogene; 1991 Sep; 6(9):1657-66. PubMed ID: 1656369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. AP-1 factors play an important role in transformation induced by the v-rel oncogene.
    Kralova J; Liss AS; Bargmann W; Bose HR
    Mol Cell Biol; 1998 May; 18(5):2997-3009. PubMed ID: 9566919
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The v-Rel oncoprotein blocks apoptosis and proteolysis of I kappa B-alpha in transformed chicken spleen cells.
    White DW; Roy A; Gilmore TD
    Oncogene; 1995 Mar; 10(5):857-68. PubMed ID: 7898928
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The N-terminal env-derived amino acids of v-rel are required for full transforming activity.
    Garson K; Percival H; Kang CY
    Virology; 1990 Jul; 177(1):106-15. PubMed ID: 2162102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The RxxRxRxxC motif conserved in all Rel/kappa B proteins is essential for the DNA-binding activity and redox regulation of the v-Rel oncoprotein.
    Kumar S; Rabson AB; Gélinas C
    Mol Cell Biol; 1992 Jul; 12(7):3094-106. PubMed ID: 1620118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The v-rel oncogene of avian reticuloendotheliosis virus transforms immature and mature lymphoid cells of the B cell lineage in vitro.
    Zhang JY; Olson W; Ewert D; Bargmann W; Bose HR
    Virology; 1991 Aug; 183(2):457-66. PubMed ID: 1677223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.